NCT03359837 - Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy | Biotech Hunter

Enrollment

384

Participants

Timeline

Start Date

January 20, 2018

Primary Completion Date

June 29, 2020

Study Completion Date

June 29, 2020

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

INSULIN GLARGINE (HOE901)

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous injection"

DRUG

Insulin Glulisine

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous injection"

DRUG

Biphasic insulin aspart 30

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous injection"

DRUG

Repaglinide

"Pharmaceutical form: tablet~Route of administration: oral administration"

DRUG

Acarbose

"Pharmaceutical form: tablet~Route of administration: oral administration"

DRUG

Metformin

"Pharmaceutical form: tablet or capsule~Route of administration: oral administration"

Trial Locations (1)

CHINA, China